MA40086A1 - Anti-vasa antibodies and their methods of production and use - Google Patents
Anti-vasa antibodies and their methods of production and useInfo
- Publication number
- MA40086A1 MA40086A1 MA40086A MA40086A MA40086A1 MA 40086 A1 MA40086 A1 MA 40086A1 MA 40086 A MA40086 A MA 40086A MA 40086 A MA40086 A MA 40086A MA 40086 A1 MA40086 A1 MA 40086A1
- Authority
- MA
- Morocco
- Prior art keywords
- vasa
- antibodies
- methods
- vasa antibodies
- relates
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne des anticorps anti-vasa, en particulier des anticorps humanisés qui se lient spécifiquement à vasa avec une affinité élevée. L'invention a également trait aux séquences d'acides aminés des cdr des chaînes légères et des chaînes lourdes, ainsi qu'à des séquences consensus pour ces cdr, de ces anticorps anti-vasa. L'invention concerne également des molécules d'acide nucléique codant pour les anticorps anti-vasa, des vecteurs d'expression, des cellules hôtes, des procédés de fabrication des anticorps anti-vasa, et des procédés d'expression des anticorps anti-vasa. Enfin, l'invention porte sur des procédés d'utilisation des anticorps anti-vasa pour isoler et/ou purifier des cellules exprimant vasa.The present invention relates to anti-vasa antibodies, particularly humanized antibodies that specifically bind to vasa with high affinity. The invention also relates to the amino acid sequences of the cdr of light and heavy chains, as well as to consensus sequences for these cdr, of these anti-vasa antibodies. The invention also relates to nucleic acid molecules encoding anti-vasa antibodies, expression vectors, host cells, methods of making anti-vasa antibodies, and methods of expressing anti-vasa antibodies. . Finally, methods for using anti-vasa antibodies to isolate and / or purify vasa-expressing cells are provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462051130P | 2014-09-16 | 2014-09-16 | |
PCT/US2015/050449 WO2016044436A2 (en) | 2014-09-16 | 2015-09-16 | Anti-vasa antibodies, and methods of production and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MA40086A1 true MA40086A1 (en) | 2019-07-31 |
Family
ID=58698591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA40086A MA40086A1 (en) | 2014-09-16 | 2015-09-16 | Anti-vasa antibodies and their methods of production and use |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR101891A1 (en) |
MA (1) | MA40086A1 (en) |
-
2015
- 2015-09-16 AR ARP150102964A patent/AR101891A1/en unknown
- 2015-09-16 MA MA40086A patent/MA40086A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR101891A1 (en) | 2017-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49599B1 (en) | Antibodies specific to cd47 and pd-l1 | |
EA201890866A1 (en) | BINDING MOLECULES THAT INHIBIT CANCER GROWTH | |
PH12018500482A1 (en) | Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies | |
MA43028B1 (en) | Bispecific antibodies for pd1 and tim3 | |
AU2016320748A8 (en) | Thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of using the antibodies | |
PH12013501652A1 (en) | Anti-vegf antibodies | |
CA2868907C (en) | Anti-hla-b*27 antibodies and uses thereof | |
EA201492101A1 (en) | ANTIBODIES AGAINST FCRN | |
EA200802168A1 (en) | HUMANIZED ANTIBODY TO C-KIT | |
MX347020B (en) | Antibody against the csf-1r. | |
EA201891573A1 (en) | CONJUGAT THERAPEUTIC ENZYMES | |
EA201600276A1 (en) | ANTI-IL-17-ANTIBODIES, METHOD OF THEIR RECEIVING AND METHOD OF APPLICATION | |
MA47221A1 (en) | Monoclonal antibody to pd-l1 | |
MX2021000708A (en) | Heavy chain antibodies binding to cd19. | |
EA201792055A1 (en) | ANTIBODIES AGAINST CD48 AND THEIR CONJUGATES | |
PH12017500309A1 (en) | Anti-vasa antibodies, and methods of production and use thereof | |
EA201492163A1 (en) | HUMANIZED ANTIBODIES TO TRKA, CONTAINING AMINO ACID SUBSTITUTES | |
MX371412B (en) | Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma. | |
NZ730186A (en) | Humanized anti-hepcidin antibodies and uses thereof | |
MX2021016098A (en) | Humanized antibody molecules to cd138 and uses thereof. | |
NZ724772A (en) | Antibodies against hpa-1a | |
MA45831B1 (en) | ANTI-BEDBUG MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF | |
WO2013186630A3 (en) | Humanized antibodies to ca215 | |
MA40086A1 (en) | Anti-vasa antibodies and their methods of production and use | |
MA43600B2 (en) | Anti-il-17a, il-17f trispecific antibody and another anti-inflammatory molecule |